Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder
- PMID: 23391682
- DOI: 10.3810/pgm.2013.01.2631
Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder
Abstract
Fatigue is commonly reported in the primary care setting; however, its cause is often unclear. This article presents 3 cases involving patients with chronic fatigue syndrome who responded poorly to treatment. After clinical evaluation, all patients were found to meet criteria for attention-deficit/hyperactivity disorder (ADHD) and underwent a standard regimen of a psychostimulant medication. After treatment with psychostimulants, the 3 patients reported improved symptoms of fatigue and pain, and cognitive and core ADHD symptoms. These cases suggest that ADHD and chronic fatigue syndrome (and possibly fibromyalgia) share a common underlying mechanism. This article presents a model suggesting that over time, ADHD (predominantly inattentive type) develops into a syndrome of chronic fatigue and pain. These cases indicate that fatigue may be an important presenting symptom of adult ADHD. These cases also suggest the need for additional research to determine the prevalence of ADHD in patients who present with fatigue, and, in those meeting criteria for ADHD, the responsiveness of fatigue to psychostimulant treatment.
Similar articles
-
Fibromylagia, chronic fatigue, and adult attention deficit hyperactivity disorder in the adult: a case study.Psychopharmacol Bull. 2007;40(1):118-26. Psychopharmacol Bull. 2007. PMID: 17285103
-
Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication.J Womens Health (Larchmt). 2005 May;14(4):345-50. doi: 10.1089/jwh.2005.14.345. J Womens Health (Larchmt). 2005. PMID: 15916509
-
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017. Clin Ther. 2007. PMID: 17692731 Clinical Trial.
-
Attention-deficit hyperactivity disorder.Clin Pharm. 1990 Aug;9(8):632-42. Clin Pharm. 1990. PMID: 1974836 Review.
-
Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.Am J Manag Care. 2009 May;15(5 Suppl):S129-40. Am J Manag Care. 2009. PMID: 19601688 Review.
Cited by
-
Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole.Front Pain Res (Lausanne). 2023 Jun 5;4:1159134. doi: 10.3389/fpain.2023.1159134. eCollection 2023. Front Pain Res (Lausanne). 2023. PMID: 37342213 Free PMC article.
-
Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder.Sci Rep. 2023 Jan 30;13(1):1678. doi: 10.1038/s41598-023-28931-3. Sci Rep. 2023. PMID: 36717626 Free PMC article.
-
Attention-Deficit/hyperactivity disorder and centralized pain: A review of the case of John F. Kennedy.Clin Case Rep. 2022 Oct 8;10(10):e6422. doi: 10.1002/ccr3.6422. eCollection 2022 Oct. Clin Case Rep. 2022. PMID: 36245472 Free PMC article.
-
Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine.Front Pain Res (Lausanne). 2022 Jul 22;3:926946. doi: 10.3389/fpain.2022.926946. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 35935670 Free PMC article.
-
Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C.Acta Pharmacol Sin. 2018 Jan;39(1):140-153. doi: 10.1038/aps.2017.84. Epub 2017 Sep 7. Acta Pharmacol Sin. 2018. PMID: 28880015 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
